{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:37:01Z","timestamp":1772120221643,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.euf.2024.09.013","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T01:06:43Z","timestamp":1728004003000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary Bladder"],"prefix":"10.1016","volume":"11","author":[{"given":"Mario","family":"de Angelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Siech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natali","family":"Rodriguez Pe\u00f1aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Puliatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2024.09.013_b0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.09.013_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2022.04.017","article-title":"Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial","volume":"82","author":"Hall","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.09.013_b0015","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2010.28.4950","article-title":"Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma","volume":"28","author":"Hoskin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.09.013_b0020","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2024.09.013_b0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cancers16071292","article-title":"Non-surgical bladder-sparing multimodal management in organ-confined urothelial carcinoma of the urinary bladder: a population-based analysis","volume":"16","author":"de Angelis","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euf.2024.09.013_b0030","doi-asserted-by":"crossref","unstructured":"Kool R, Dragomir A, Kulkarni GS, et al. Benefit of neoadjuvant cisplatin-based chemotherapy for invasive bladder cancer patients treated with radiation-based therapy in a real-world setting: an inverse probability treatment weighted analysis. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2024.01.014.","DOI":"10.1016\/j.euo.2024.01.014"},{"key":"10.1016\/j.euf.2024.09.013_b0035","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1016\/j.clgc.2021.03.010","article-title":"Radical cystectomy vs. multimodality treatment in T2N0M0 bladder cancer: a population-based, age-matched analysis","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2024.09.013_b0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MOU.0000000000001113","article-title":"Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer","volume":"33","author":"De Angelis","year":"2023","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euf.2024.09.013_b0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3857\/roj.2023.00262","article-title":"Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer","volume":"41","author":"Vieira","year":"2023","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.euf.2024.09.013_b0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2024.09.013_b0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urolonc.2020.10.005","article-title":"Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer","volume":"41","author":"Ballas","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2024.09.013_b0060","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(13)70255-9","volume":"14","author":"Mitin","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2024.09.013_b0065","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.3390\/cancers14235766","article-title":"Differences in cancer-specific mortality after trimodal therapy for T2N0M0 bladder cancer according to histological subtype","volume":"14","author":"Barletta","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euf.2024.09.013_b0070","doi-asserted-by":"crossref","first-page":"272.e1","DOI":"10.1016\/j.urolonc.2021.12.015","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder","volume":"40","author":"Softness","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2024.09.013_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.4372","article-title":"Comparison of costs of radical cystectomy vs trimodal therapy for patients with localized muscle-invasive bladder cancer","volume":"154","author":"Williams","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.euf.2024.09.013_b0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.juro.2018.06.001","article-title":"Effectiveness of transurethral resection plus systemic chemotherapy as definitive treatment for muscle invasive bladder cancer in population level data","volume":"200","author":"Audenet","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.09.013_b0085","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.09.013_b0090","doi-asserted-by":"crossref","unstructured":"de Angelis M, Baudo A, Siech C, et al. Trimodal therapy effect on survival in urothelial vs non\u2010urothelial bladder cancer. BJU Int. In press. https:\/\/doi.org\/10.1111\/bju.16333.","DOI":"10.1111\/bju.16333"},{"key":"10.1016\/j.euf.2024.09.013_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2020.07.011","article-title":"Bladder cancer: a comparison between non-urothelial variant histology and urothelial carcinoma across all stages and treatment modalities","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2024.09.013_b0100","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1200\/JCO.2016.69.2327","article-title":"Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic","volume":"35","author":"Kulkarni","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924001809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924001809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:16:17Z","timestamp":1760073377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456924001809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2405456924001809"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2024.09.013","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary Bladder","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2024.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}